Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
RESEARCH TOOLSreports
KalVista Pharmaceuticals (KALV) Ownership - Who Owns KalVista Pharmaceuticals?
357 Followers
KalVista Pharmaceuticals (KALV) Ownership Overview
72.67% Insiders
10.67% Mutual Funds
9.89% Other Institutional Investors
6.77% Public Companies and Individual Investors
The ownership structure of KalVista Pharmaceuticals (KALV) stock is a mix of institutional, retail and individual investors. Approximately 20.55% of the company’s stock is owned by Institutional Investors, 72.67% is owned by Insiders and 6.77% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 16, 2024 | Benjamin L Palleiko Ceo,director | xxxxxxxxxxxxx | $612825 |
| Feb 16, 2024 | xxxxxxxxxxxxx | $422565 | |
| Feb 16, 2024 | xxxxxxxxxxxxx | $598290 | |
| Feb 16, 2024 | Thomas Andrew Crockett Ceo,director | xxxxxxxxxxxxx | $875340 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $92318 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $182086 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $1784479 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $5930000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,619,196 | Insider | 10.81% | 67,209,302 | |
| 4,343,550 | Insider | 10.16% | 63,198,653 | |
| 4,343,550 | Insider | 10.16% | 63,198,653 | |
| 4,204,564 | Insider | 9.84% | 61,176,406 | |
| 1,869,469 | Institution | 4.37% | 27,200,774 | |
| 1,740,105 | Institution | 4.07% | 25,318,528 | |
| 1,423,318 | Institution | 3.33% | 20,709,277 | |
| 541,538 | Institution | 1.27% | 7,879,378 | |
| 500,000 | Institution | 1.17% | 7,275,000 | |
| 456,400 | Institution | 1.07% | 6,640,620 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,423,318 | Institution | 3.33% | 20,709,277 | |
| 456,400 | Institution | 1.07% | 6,640,620 | |
| 406,200 | Institution | 0.95% | 5,910,210 | |
| 378,928 | Institution | 0.89% | 5,513,402 | |
| 337,287 | Institution | 0.79% | 4,907,526 | |
| 293,180 | Institution | 0.69% | 4,265,769 | |
| 279,983 | Institution | 0.66% | 4,073,753 | |
| 135,847 | Institution | 0.32% | 1,976,574 | |
| 117,924 | Institution | 0.28% | 1,715,794 | |
| 108,104 | Institution | 0.25% | 1,572,913 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,007,110 | Institution | 2.36% | 14,653,451 | |
| 1,084,834 | Institution | 2.54% | 12,779,345 | |
| 557,268 | Institution | 1.30% | 6,564,617 | |
| 339,908 | Institution | 0.80% | 4,945,661 | |
| 205,912 | Institution | 0.48% | 2,996,020 | |
| 141,779 | Institution | 0.33% | 1,670,157 | |
| 85,711 | Institution | 0.20% | 1,247,095 | |
| 49,719 | Institution | 0.12% | 706,010 | |
| 44,817 | Institution | 0.10% | 652,087 | |
| 43,016 | Institution | 0.10% | 610,827 |
FAQ
Who Owns KalVista Pharmaceuticals (KALV)?
According to the latest TipRanks data, approximately 9.89% of the company's stock is held by institutional investors, 72.67% is held by insiders, and 6.77% is held by retail investors.
What percentage of KalVista Pharmaceuticals (KALV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.89% of KalVista Pharmaceuticals (KALV) stock is held by institutional investors.
What percentage of KalVista Pharmaceuticals (KALV) stock is held by retail investors?
According to the latest TipRanks data, approximately 6.77% of KalVista Pharmaceuticals (KALV) stock is held by retail investors.
Who owns the most shares of KalVista Pharmaceuticals (KALV)?
Interwest Management Partners Ix, Llc owns the most shares of KalVista Pharmaceuticals (KALV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.